About The Science


Biscayne’s development program is protected by a substantial intellectual property portfolio.

For the BIS-001 epilepsy program, Biscayne has exclusive worldwide licenses to patents from Harvard University, Yale University, and the University of South Florida. The patent portfolio currently includes 6 issued patents and 15 pending applications covering route of manufacturing and methods of use in a variety of clinical applications.